아포토시스 어세이 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 검출 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Apoptosis Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Detection Technology, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1668098
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
아포토시스 어세이 세계 시장 규모는 2024년 55억 1,000만 달러로 평가되며, 예측 기간 동안 6.21%의 CAGR로 2030년에는 66억 8,000만 달러에 달할 것으로 예상됩니다.
아포토시스 어세이는 다양한 생물학적 샘플에서 프로그램된 세포사멸(apoptosis)을 연구하기 위해 생물 의학 연구 및 의약품 개발에 사용되는 중요한 도구입니다. 이러한 분석은 암 연구, 신경생물학, 면역학, 약물 스크리닝 등 다양한 응용 분야에 필수적인 세포사멸의 메커니즘과 조절을 이해하는 데 도움이 됩니다. 아포토시스 어세이 시장에는 어세이 키트, 기기, 시약, 시약, 소프트웨어 솔루션 등 다양한 제품과 서비스가 포함됩니다. 면역학 분야에서는 면역 반응과 자가면역질환의 발병에 있어 세포사멸의 역할이 밝혀지고 있습니다. 류마티스 관절염이나 루푸스와 같은 자가면역질환에 대한 연구는 새로운 치료 대상을 밝혀내고 있습니다. 아포토시스 어세이는 면역세포의 세포사멸을 조절하는 잠재적 약물의 스크리닝에 필수적이며, 시장 성장의 새로운 기회를 제공하고 있습니다. 아포토시스 어세이는 민감도, 정확도, 사용 편의성이 향상됨에 따라 연구자 및 제약사들은 아포토시스 어세이를 채택하는 경향이 있습니다. 첨단 아포토시스 어세이는 맞춤의료, 약물 스크리닝, 질병 모델링 등 새로운 연구 분야와 응용 분야의 문을 열어줄 것입니다. 이 시장은 전용 어세이 키트, 기기, 시약, 시약, 소프트웨어 솔루션 등 다양한 제품 라인업을 갖추고 있습니다. 혁신적인 아포토시스 어세이 제품을 제공하려는 기업 간의 경쟁은 기술 발전을 촉진하고 다양한 선택권을 제공함으로써 최종사용자에게 이익을 가져다 줄 것입니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
55억 1,000만 달러
시장 규모 : 2030년
66억 8,000만 달러
CAGR : 2025-2030년
6.21%
급성장 부문
어세이 키트
최대 시장
북미
시장 촉진요인
생물 의학 연구의 발전
주요 시장 과제
아포토시스 경로의 복잡성
실험에서 의미 있는 결과를 도출하기 위해서는 효율적인 데이터 분석 도구와 전문 지식이 필요합니다.
주요 시장 동향
암 연구에서의 중요한 역할 증가
지역별 인사이트
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 아포토시스 어세이 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(어세이 키트, 시약, 기기, 마이크로플레이트)
검출 기술별(분광광도계, 유세포 분석, 세포 이미징과 분석 시스템, 기타)
용도별(줄기세포 조사, 임상과 진단 용도, Drug Discovery & Development, 기타)
최종사용자별(제약·바이오테크놀러지 기업, 병원·실험실, 학술·연구기관)
지역별
기업별(2024년)
시장 맵
제6장 북미의 아포토시스 어세이 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 아포토시스 어세이 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 아포토시스 어세이 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
일본
한국
호주
제9장 남미의 아포토시스 어세이 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 아포토시스 어세이 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(해당되는 경우)
제품 발매(해당되는 경우)
제13장 Porter's Five Forces 분석
산업내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
Thermo Fisher Scientific Inc
Merck KGaA
Bio-Rad Laboratories Inc
GE Healthcare Inc
Becton Dickinson & Company
Sartorius AG
Genecopoeia Inc
BioTek Instruments Inc
Bio-Techne Corporation
PerkinElmer Health Sciences Inc
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
Global Apoptosis Assays Market was valued at USD 5.51 Billion in 2024 and is expected to reach USD 6.68 Billion by 2030 with a CAGR of 6.21% during the forecast period. Apoptosis assays are crucial tools used in biomedical research and drug development to study programmed cell death (apoptosis) in various biological samples. These assays help researchers understand the mechanisms and regulation of apoptosis, which is essential for a wide range of applications, including cancer research, neurobiology, immunology, and drug screening. The market for apoptosis assays includes a variety of products and services, such as assay kits, instruments, reagents, and software solutions. The field of immunology is uncovering the role of apoptosis in regulating immune responses and the development of autoimmune disorders. Research into autoimmune diseases like rheumatoid arthritis and lupus is revealing novel targets for therapy. Apoptosis assays are essential in screening potential drugs that modulate immune cell apoptosis, offering new opportunities for market growth. Researchers and pharmaceutical companies are more inclined to adopt apoptosis assays due to their improved sensitivity, precision, and ease of use. Advanced apoptosis assays open doors to new research areas and applications, including personalized medicine, drug screening, and disease modeling. The market witnesses an expansion of product offerings, including specialized assay kits, instruments, reagents, and software solutions. Competition among companies to provide innovative apoptosis assay products drives technological advancements and benefits end-users by offering a wider range of options.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.51 Billion
Market Size 2030
USD 6.68 Billion
CAGR 2025-2030
6.21%
Fastest Growing Segment
Assay Kits
Largest Market
North America
Key Market Drivers
Advancements in Biomedical Research
Biomedical research is at the forefront of scientific innovation, constantly seeking to unravel the mysteries of human health and disease. Within this dynamic field, the study of apoptosis, a highly regulated process of programmed cell death, has emerged as a critical area of investigation. Advancements in biomedical research are not only expanding our understanding of apoptosis but also fueling the growth of the global apoptosis assays market. Apoptosis, or programmed cell death, is a fundamental biological process that plays a pivotal role in various physiological functions, including tissue homeostasis, development, and immune response. Dysregulation of apoptosis is associated with numerous diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. As researchers delve deeper into the intricate mechanisms of apoptosis, the demand for robust apoptosis assays has surged, contributing significantly to market growth.
One of the primary ways advancements in biomedical research drive the apoptosis assays market is through target identification and drug discovery. As researchers uncover novel molecular pathways and specific proteins involved in apoptosis, they identify potential drug targets. Apoptosis assays serve as essential tools to evaluate the efficacy of candidate drugs in modulating cell death processes. The discovery of new drug targets fuels the demand for apoptosis assays, as pharmaceutical companies require accurate and high-throughput methods for drug screening. Biomedical research has ushered in the era of personalized medicine, where treatment approaches are tailored to individual patients based on their genetic makeup and disease profiles. Apoptosis assays play a crucial role in the development of biomarkers that can predict patient responses to specific therapies. As researchers uncover unique apoptosis signatures associated with different diseases and drug responses, the demand for specialized apoptosis assays increases, benefiting the market.
Key Market Challenges
Complexity of Apoptosis Pathways
Apoptosis is a highly complex and tightly regulated process with multiple pathways. The diversity of apoptosis mechanisms can pose challenges when designing assays that accurately reflect the intricacies of cell death. Researchers often face the task of selecting the most appropriate assay for their specific research question or disease model.
require efficient data analysis tools and expertise to extract meaningful insights from their experiments.
Key Market Trends
Growing Pivotal Role in Cancer Research
Cancer remains one of the most formidable challenges in modern medicine, affecting millions of lives worldwide. The fight against cancer has led to remarkable advancements in the field of oncology, and researchers are increasingly turning to apoptosis assays to decipher the intricacies of this devastating disease. Cancer is characterized by uncontrolled cell growth and the ability of malignant cells to evade programmed cell death, a process known as apoptosis. Apoptosis is crucial in maintaining cellular homeostasis, and its dysregulation can lead to the development and progression of tumors. Consequently, apoptosis plays a central role in cancer research, diagnosis, and therapy.
Identifying specific molecular targets within apoptotic pathways is essential for developing targeted cancer therapies. Apoptosis assays help researchers pinpoint these targets, enabling the development of drugs that selectively induce apoptosis in cancer cells. The development of novel cancer therapeutics requires rigorous screening of potential drug candidates. Apoptosis assays provide a means to assess the cytotoxic effects of compounds on cancer cells, helping researchers identify promising drug candidates while minimizing harm to healthy cells. Monitoring the efficacy of cancer treatments is paramount. Apoptosis assays allow researchers and clinicians to evaluate how well a therapy induces cell death in tumors. This information guides treatment decisions and helps determine the most effective regimens for individual patients. Resistance to cancer treatments is a significant challenge. Apoptosis assays can help identify mechanisms of drug resistance by examining how cancer cells evade apoptosis. This knowledge informs the development of strategies to overcome resistance.
Regional Insights
North America maintains its market leadership and is projected to continue its dominance in the apoptosis assay market during the forecast period. This can be attributed to several factors, including the increasing prevalence of chronic diseases like cancer and the presence of advanced healthcare infrastructure. Within North America, the United States stands out as the frontrunner, primarily due to factors such as a growing population afflicted with autoimmune and chronic illnesses, a rising elderly demographic, and advancements in the field of drugs that modulate apoptosis. These factors are expected to drive demand in this region.
Key Market Players
Thermo Fisher Scientific Inc
Merck KGaA
Bio-Rad Laboratories Inc
GE Healthcare Inc
Becton Dickinson & Company
Sartorius AG
Genecopoeia Inc
BioTek Instruments Inc
Bio-Techne Corporation
PerkinElmer Health Sciences Inc.
Report Scope:
In this report, the Global Apoptosis Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Apoptosis Assays Market, By Product:
Assay Kits
Reagents
Instruments
Microplates
Apoptosis Assays Market, By Detection Technology:
Spectrophotometry
Flow Cytometry
Cell Imaging and Analysis Systems
Others
Apoptosis Assays Market, By Application:
Stem Cell Research
Clinical and Diagnostics Application
Drug Discovery and Development
Others
Apoptosis Assays Market, By End User:
Pharmaceutical and Biotechnology Companies
Hospital and Laboratories
Academic and Research Institutes
Apoptosis Assays Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Apoptosis Assays Market.
Available Customizations:
Global Apoptosis Assays market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Apoptosis Assays Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Assay Kits, Reagents, Instruments, Microplates)
5.2.2. By Detection Technology (Spectrophotometry, Flow Cytometry, Cell Imaging and Analysis Systems, Others)
5.2.3. By Application (Stem Cell Research, Clinical and Diagnostics Application, Drug Discovery and Development, Others)
5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Hospital and Laboratories, Academic and Research Institutes)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Apoptosis Assays Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Detection Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Apoptosis Assays Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Detection Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Apoptosis Assays Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Detection Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Apoptosis Assays Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Detection Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Apoptosis Assays Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Detection Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Apoptosis Assays Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Detection Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. United Kingdom Apoptosis Assays Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Detection Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Italy Apoptosis Assays Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Detection Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. France Apoptosis Assays Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Detection Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Apoptosis Assays Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Detection Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Apoptosis Assays Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Detection Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Apoptosis Assays Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Detection Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Apoptosis Assays Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Detection Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Apoptosis Assays Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Detection Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Apoptosis Assays Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Detection Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Apoptosis Assays Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Detection Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Apoptosis Assays Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Detection Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Apoptosis Assays Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Detection Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Apoptosis Assays Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Detection Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Apoptosis Assays Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Detection Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Apoptosis Assays Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Detection Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Apoptosis Assays Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Detection Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Apoptosis Assays Market Outlook
